Musk Slams Altman Trial Verdict as Technicality Vows to Appeal NCR Voyix VYX Down 296 How Low Could It Go 20260515 Dine Brands DIN Q1 2026 Beat Revenue NA EPS Exceeds by Significant Traders Bet Big on Boeing Deal and Tariff Truce Extension as Trump Heads to Beijing Illinois Payrolls Rise in March Unemployment Rate Edges Higher SpaceX Successfully Launches Starship in Second Attempt Advancing HeavyLift Capabilities Asian Markets Edge Higher Oil Retreats as Trump Signals Iran Peace Talks Myanmars Political Transition Requires Press Freedom Benchmarks CPJ Urges Wedbush Raises Tower Semiconductor Price Target to 300 Citing Positive Q1 Commentary and Optical Networking Transition Markets Reprice Fed Rate Path Hot Inflation Data Raises Possibility of Rate Hike Before 2027 Polar Power Inc POLA Q1 2026 Earnings Narrowed Loss and Quiet Revenue Disclosure Lift Shares VERI Q1 2026 Earnings EPS Misses Estimates Stock Falls Over 6 ROC Q1 2026 Earnings Significant EPS Surprise Fuels Optimism OLLI Q1 2026 Earnings EPS Slightly Misses Estimates as Stock Dips Flowserve Corporation FLS Q1 2026 Earnings EPS Surprise Beats Estimates Amid Operational Discipline High Tide Inc HITI Slips 205 as Traders Eye Key Support at 227 Synaptics Shares Decline 4 as Support Level Nears Potential Bounce or Breakdown Ahead STAK Inc STAK Slips 452 as It Tests Key Support Near 090 Ecovyst Inc ECVT Slides as Stock Tests Key Support Level Near 1320 TIC Solutions Inc Q1 2026 Earnings Deep EPS Miss Highlights Ongoing Cost Pressures ECL Q1 2026 Earnings EPS Misses Estimates Modestly Stock Rises on Operational Strength NVVE Q2 2025 Earnings Wide Loss Reported Amidst Operational Challenges Stock Gains 69 KOP Q1 2026 Earnings Strong EPS Beat Driven by Operational Efficiency FUFU Q4 2025 Earnings Massive EPS Miss Underscores Bitcoin Mining Headwinds Allient Inc ALNT Q1 2026 Earnings EPS Misses Estimates but Stock Surges Over 12 Fed Minutes Reveal Officials Anticipate Rate Hikes If Iran War Keeps Inflation Elevated CBIO Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Progresses